Cargando…
Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints
METHODS: This multicenter, double-blind, placebo-controlled, parallel-group trial included adults with chronic idiopathic constipation randomized to polyethylene glycol 3350 17 g (n = 204) or placebo (n = 100) once daily for 24 weeks. Post hoc analyses were performed using the US Food and Drug Admin...
Autores principales: | Menees, Stacy B., Lembo, Anthony J., Chey, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481403/ https://www.ncbi.nlm.nih.gov/pubmed/36120087 http://dx.doi.org/10.1155/2022/3533504 |
Ejemplares similares
-
Polyethylene Glycol 3350 With Electrolytes Versus Polyethylene Glycol 4000 for Constipation: A Randomized, Controlled Trial
por: Bekkali, Noor L.H., et al.
Publicado: (2018) -
Safety of polyethylene glycol 3350 solution in chronic constipation: randomized, placebo-controlled trial
por: McGraw, Thomas
Publicado: (2016) -
Polyethylene glycol 3350 plus electrolytes for pediatric chronic constipation: An open‐label clinical study in Japan
por: Gondo, Mayuko, et al.
Publicado: (2020) -
Using Polyethylene Glycol 3350 Plus Electrolytes in Constipated Hemodialysis Patients: A Case Series
por: Endo, Hiroyuki, et al.
Publicado: (2020) -
Clinical efficacy and safety of polyethylene glycol 3350 versus liquid paraffin in the treatment of pediatric functional constipation
por: Rafati, MR., et al.
Publicado: (2011)